Stefrab-LS

Rabeprazole 20 mg +Levosulpiride 75 mg Sustained Release Capsules

The Clinically Excellent Therapy to Control GI Discomforts

Rabeprazole: Potent & Effective PPI

– Rabeprazole 20 mg is sufficient to block the maximum amount of proton pumps
– Rapidly suppresses acid & ensures sustained action
– Effectively controls reflux esophagitis maa 0r a
– Ensures prolonged safety in lona term maintenance therapy

Levosulpiride Superior to Domperidone & Other Prokinetics

-Exerts prokinetic action thrOugh dual mechanism:

1) as a D dopamine receptor antagonist and

2) as a serotonin SHTa receptor aganist,
– At a dosage of 75mg SR daily, Ievosulpiride accelerates gastric
and gallbladder emptying.
– More effective in reducing symptoms of dyspepsia, as compared
to other dopamine antagonists